Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10947317 NaPi2b-targeted antibody-drug conjugates and methods of use thereof

Patent 10947317 was granted and assigned to Mersana Therapeutics on March, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+311 characters)
Article

Patent abstract

This disclosure provides NaPi2b-targeted antibody-drug conjugates (e.g., NaPi2b-targeted antibody-polymer-drug conjugates) that specifically bind to the extracellular region of SLC34A2, and to methods of using such conjugates in a variety of therapeutic, diagnostic, and prophylactic indications.

Edits on 18 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 18 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11786605 Site specific antibody-drug conjugates with peptide-containing linkers
Edits on 9 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2023
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Aleksandr V. Yurkovetskiy0
Donald A. Bergstrom0
Laura L. Poling0
Natalya D. Bodyak0
Peter U. Park0
Timothy B. Lowinger0
Edits on 26 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 26 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109473170
Edits on 3 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11638760 Pyrrolobenzodiazepine antibody conjugates
0
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 8 Mar, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Mar, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11596694 Compositions and methods for predicting response to NaPi2b-targeted therapy
0
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Mersana Therapeutics
Mersana Therapeutics
0
Current Assignee
Mersana Therapeutics
Mersana Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109473170
Date of Patent
March 16, 2021
0
Patent Application Number
154575740
Date Filed
March 13, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109473170
Patent Citations Received
‌
US Patent 11407825 NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof
0
Patent Primary Examiner
‌
Karen A. Canella
0
Edits on 10 Aug, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Aug, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11407825 NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10947317
Edits on 10 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 10 Feb, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10947317 NaPi2b-targeted antibody-drug conjugates and methods of use thereof

Infobox
Is a
Patent
Patent
Patent applicant
Mersana Therapeutics
Mersana Therapeutics
Current assignee
Mersana Therapeutics
Mersana Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10947317
Date of patent
March 16, 2021
Patent application number
15457574
Date Filed
March 13, 2017
Patent primary examiner
‌
Karen A. Canella

Find more entities like US Patent 10947317 NaPi2b-targeted antibody-drug conjugates and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo